BUZZ-Citi cuts PT on Pfizer as revenue flattens
** Citi Research cuts PT on pharmaceutical giant Pfizer PFE.N to $29 from $30, citing stagnant revenue growth and policy changes
** Brokerage says specialty care business will be affected by Inflation Reduction Act part D changes, which will affect how Medicare beneficiaries pay for prescription drugs
** "While company is tightlipped on Danuglipron future, they are all in on obesity and continue to develop additional next gen molecules demonstrating continued interest," brokerage says
** New PT represents 8% upside to stock's last close
** PFE, set to release its Q4 earnings next week, beat adjusted EPS estimates for 15 straight quarters
** 12 of 26 brokerages rate stock "buy" or higher, 13 "hold" and 1 "sell" or lower; median PT is $31.5 - LSEG data
** Stock fell 8% in 2024, compared with 23% increase in S&P 500 index .SPX
Related Articles
The Market Game of the Quantitative King: How Renaissance Technologies Locks in Excess Returns Amid the 2025 Turmoil
TradingKey - Founded by mathematician James Simons, Renaissance Technologies LLC is a global leader in quantitative investing, renowned for its data-driven, innovative approach. The firm eschews traditional fundamental analysis, relying instead on advanced mathematical models
Bridgewater Associates Q2 2025 13F Analysis: Founder Ray Dalio’s Final Act
TradingKey - Bridgewater Associates, the world’s largest hedge fund and renowned for its macroeconomic analysis, continues to command market respect with its “risk parity” strategy and precise economic cycle timing..jpg)
U.S. July CPI Commentary: Obstacles Cleared, Where Will U.S. Stocks Go Next?
TradingKey - On 12 August 2025, the United States released its Consumer Price Index (CPI) data for July. In terms of headline inflation, the CPI rose by 2.7% year-on-year in the month, slightly lower than the expected 2.8%. However, core CPI climbed 3.1% year-on-year, edging past the projected 3.0%.
Which Crypto Companies Are Filing for IPOs — and Who Might Be the Next Circle?
Circle’s IPO has opened the floodgates for crypto firms to tap public markets. From Gemini and Bullish to Kraken and ConsenSys, the next wave of listings is already forming.
[IN-DEPTH ANALYSIS] UnitedHealth (UNH): Can the Healthcare Giant Recover After Its Epic Collapse?
Once a Wall Street sweetheart, UnitedHealth Group (UNH) dominated the US healthcare industry with its unbeatable vertical empire, spanning insurance, clinics, pharmacies, and data analytics..jpg)
